Vertex Pharmaceuticals
VRTX
#150
Rank
C$192.97 B
Marketcap
C$761.13
Share price
2.06%
Change (1 day)
28.74%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): C$6.37 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$12.95 Billion. In 2025 the company made an earning of C$6.90 Billion, an increase over its 2024 earnings that were of C$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$6.37 B-7.64%
2025 C$6.90 B1627.59%
2024 C$0.39 B-93.69%
2023 C$6.33 B3.19%
2022 C$6.14 B53.56%
2021 C$3.99 B-12.06%
2020 C$4.54 B118.45%
2019 C$2.08 B120.64%
2018 C$0.94 B1473.64%
2017 C$59.96 M197.6%
2016 C$20.14 M-102.97%
2015 -C$0.68 Billion-28.46%
2014 -C$0.95 Billion-51.5%
2013 -C$1.96 Billion-30584.68%
2012 C$6.41 M-95.47%
2011 C$0.14 B
2009 -C$0.85 Billion
2007 -C$0.6 Billion83.1%
2006 -C$0.33 Billion59.02%
2005 -C$0.21 Billion3.28%
2004 -C$0.2 Billion-38.16%
2003 -C$0.32 Billion
2000 -C$54.5 Million-20.38%
1999 -C$68.44 Million31.62%
1998 -C$52 Million91.05%
1997 -C$27.22 Million-36.24%
1996 -C$42.69 Million12.45%
1995 -C$37.96 Million27.4%
1994 -C$29.8 Million-1833.33%
1993 C$1.71 M-112.12%
1992 -C$14.19 Million175%
1991 -C$5.16 Million-12.2%
1990 -C$5.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.81 B 310.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$18.35 B 180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$3.63 Billion-155.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.63 B 47.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.23 B 148.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$71.93 Million-101.10%๐Ÿ‡บ๐Ÿ‡ธ USA